Table 3.
Summary of the clinico-pathological data for the eight PDHGG primary patient-derived cell lines used for the study.
| Patient cell line | Gender | Age (years) | Procedure | Diagnosis | Location | Mutation | ||
|---|---|---|---|---|---|---|---|---|
| OPBG-GBM002 | M | 11 | Resection | PDHGG-WT | Hemispheric | WT | ||
| OPBG-GBM005 | M | 9 | Resection | PDHGG-WT | Hemispheric | WT | ||
| OPBG-GBM001 | M | 12 | Resection | DHG-H3G34 | Hemispheric | H3.3G34R | ||
| HSJD-GBM002 | M | 14 | Biopsy | DHG-H3G34 | Hemispheric | H3.3G34R | ||
| OPBG-DIPG002 | F | 6 | Biopsy | DMG-H3K27 | Pons | H3.3K27M | ||
| OPBG-DIPG019 | M | 8 | Biopsy | DMG-H3K27 | Pons | H3.3K27M | ||
| OPBG-DIPG004 | M | 6 | Biopsy | DMG-H3K27 | Pons | H3.1K27M | ||
| OPBG-DIPG015 | F | 4 | Biopsy | DMG-H3K27 | Pons | H3.1K27M | ||
The panel shows the information regarding the patients’ gender and age, as well as the type of procedure, diagnosis, tumor location and mutation status.